Retinal Vein Occlusion
Showing NaN - NaN of 8
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)
Terminated
- Wet Age-related Macular Degeneration
- +2 more
-
Phoenix, Arizona
- +10 more
Nov 1, 2022
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))
Completed
- Retinal Vein Occlusion
- Macula Edema
- TLC399 (ProDex)
-
Phoenix, Arizona
- +19 more
Nov 24, 2021
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Phoenix, Arizona
- +91 more
Apr 22, 2021
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Peoria, Arizona
- +109 more
Mar 18, 2021
Macular Edema, Retinal Vein Occlusion Trial in United States (4 mg CLS-TA, Sham, IVT aflibercept)
Completed
- Macular Edema
- Retinal Vein Occlusion
- 4 mg CLS-TA
- +2 more
-
Phoenix, Arizona
- +13 more
Jan 18, 2021
Retinal Vein Occlusion, Diabetic Macular Edema Trial in Beverly Hills, Boston (KPI-121 0.25% Ophthalmic Suspension, KPI-121 1.0%
Completed
- Retinal Vein Occlusion
- Diabetic Macular Edema
- KPI-121 0.25% Ophthalmic Suspension
- KPI-121 1.0% Ophthalmic Suspension
-
Beverly Hills, California
- +1 more
Dec 9, 2020
Retinal Vein Occlusion Trial in United States (ranibizumab, Peripheral Laser)
Completed
- Retinal Vein Occlusion
- ranibizumab
- Peripheral Laser
-
Beverly Hills, California
- +5 more
Nov 27, 2013